» Articles » PMID: 39290379

Preventing SARS-CoV-2 Infection Using Fv-antibodies Targeting the Proprotein Convertase (PPC) Cleavage Site

Overview
Journal RSC Med Chem
Specialty Chemistry
Date 2024 Sep 18
PMID 39290379
Authors
Affiliations
Soon will be listed here.
Abstract

Fv-antibodies targeting the proprotein convertase (PPC) region of the SARS-CoV-2 spike protein (SP) were screened from an Fv-antibody library to inhibit SARS-CoV-2 infection. Two selected Fv-antibodies were expressed as soluble recombinant proteins, and their binding affinities were assessed using a surface plasmon resonance biosensor. The binding regions of these Fv-antibodies corresponded to the cleavage sites of furin (S1/S2) and transmembrane serine protease 2 (TMPRSS2, S2'). The neutralizing activities of the two Fv-antibodies were demonstrated using a cell-based infection assay with pseudo-viruses carrying the SP of four different SARS-CoV-2 variants: wild-type (D614), delta (B.1.617.2), omicron (BA.2), and omicron (BA.4/5).

Citing Articles

Transmembrane protease serine 2 (TMPRSS2) inhibitors screened from an Fv-antibody library for preventing SARS-CoV-2 infection.

Jung J, Sung J, Kwon S, Bae H, Kang M, Jose J RSC Med Chem. 2025; .

PMID: 39990164 PMC: 11843257. DOI: 10.1039/d4md00992d.


Screened Fv-Antibodies against the Angiotensin-Converting Enzyme 2 (ACE2) Receptor Neutralizing the Infection of SARS-CoV-2.

Jung J, Kwon S, Sung J, Bae H, Kang M, Jose J ACS Pharmacol Transl Sci. 2024; 7(12):3914-3920.

PMID: 39698273 PMC: 11651164. DOI: 10.1021/acsptsci.4c00441.

References
1.
Eberhardt J, Santos-Martins D, Tillack A, Forli S . AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J Chem Inf Model. 2021; 61(8):3891-3898. PMC: 10683950. DOI: 10.1021/acs.jcim.1c00203. View

2.
Kumar S, Bose D, Suryawanshi H, Sabharwal H, Mapa K, Maiti S . Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin. PLoS One. 2011; 6(8):e23300. PMC: 3154333. DOI: 10.1371/journal.pone.0023300. View

3.
Su H, Zhou F, Huang Z, Ma X, Natarajan K, Zhang M . Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2. Angew Chem Int Ed Engl. 2020; 60(18):9789-9802. DOI: 10.1002/anie.202008835. View

4.
Yang J, L Petitjean S, Koehler M, Zhang Q, Dumitru A, Chen W . Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun. 2020; 11(1):4541. PMC: 7486399. DOI: 10.1038/s41467-020-18319-6. View

5.
Jose J, Meyer T . The autodisplay story, from discovery to biotechnical and biomedical applications. Microbiol Mol Biol Rev. 2007; 71(4):600-19. PMC: 2168652. DOI: 10.1128/MMBR.00011-07. View